Integrating R&D, production, sales and technical servicesModern high-tech enterprises


GPDA Glycylproline Dipeptidyl Aminopeptidase Test Kit (Continuous Monitoring Method)

GPDA Glycylproline Dipeptidyl Aminopeptidase Test Kit (Continuous Monitoring Method)


time:2022/11/24 16:08:01




Product Introduction

[GPDA] Glycylproline dipeptidyl aminopeptidase assay kit (continuous monitoring method)

Methodology: continuous monitoring method

Dosage form: liquid double reagent

storage: 2-8 ℃ dark storage

Registration certificate: ZXZZ 20162400860.

Clinical significance: The positive rate of serum GPDA elevation in patients with primary liver cancer with negative and positive serum AFP is basically consistent, while the activity of serum GPDA in patients with hepatic hemangioma is in the normal range. The serum GPDA of more than 70% gastric cancer patients decreased significantly, and the serum GPDA of patients showed a rising trend after gastric cancer resection. Serum GPDA detection can differentiate benign and malignant liver diseases, monitor liver metastasis of cancer and gastric cancer,

Intended use: This kit is used to quantitatively determine the activity of glycylproline dipeptidyl aminopeptidase in human serum in vitro. It is mainly used for the auxiliary diagnosis of early kidney loss, rheumatoid disease and chronic hepatitis.

Manufacturer: Zhejiang Aikang Biotechnology Co., Ltd.

Related news